nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—CYP2B6—malignant glioma	0.456	0.727	CbGaD
Dexamethasone—PTGS2—malignant glioma	0.172	0.273	CbGaD
Dexamethasone—Monoplegia—Carmustine—malignant glioma	0.00823	0.0742	CcSEcCtD
Dexamethasone—Cushing's syndrome—Carmustine—malignant glioma	0.00561	0.0506	CcSEcCtD
Dexamethasone—Conjunctival oedema—Carmustine—malignant glioma	0.00459	0.0414	CcSEcCtD
Dexamethasone—Hyperaemia—Carmustine—malignant glioma	0.00421	0.038	CcSEcCtD
Dexamethasone—PLA2G1B—blood vessel—malignant glioma	0.00368	0.0707	CbGeAlD
Dexamethasone—Meningitis—Carmustine—malignant glioma	0.00328	0.0296	CcSEcCtD
Dexamethasone—Opportunistic infection—Temozolomide—malignant glioma	0.00305	0.0275	CcSEcCtD
Dexamethasone—Intracranial pressure increased—Carmustine—malignant glioma	0.00305	0.0275	CcSEcCtD
Dexamethasone—Impaired healing—Carmustine—malignant glioma	0.00294	0.0265	CcSEcCtD
Dexamethasone—Skin hyperpigmentation—Carmustine—malignant glioma	0.00214	0.0193	CcSEcCtD
Dexamethasone—Visual acuity reduced—Temozolomide—malignant glioma	0.00207	0.0186	CcSEcCtD
Dexamethasone—Embolism—Temozolomide—malignant glioma	0.00192	0.0173	CcSEcCtD
Dexamethasone—Myopathy—Temozolomide—malignant glioma	0.00175	0.0158	CcSEcCtD
Dexamethasone—PGR—blood vessel—malignant glioma	0.00169	0.0326	CbGeAlD
Dexamethasone—ANXA1—embryo—malignant glioma	0.00168	0.0323	CbGeAlD
Dexamethasone—Necrosis—Carmustine—malignant glioma	0.00162	0.0146	CcSEcCtD
Dexamethasone—Abscess—Carmustine—malignant glioma	0.00161	0.0145	CcSEcCtD
Dexamethasone—Petechiae—Temozolomide—malignant glioma	0.0015	0.0135	CcSEcCtD
Dexamethasone—Extravasation—Carmustine—malignant glioma	0.00146	0.0132	CcSEcCtD
Dexamethasone—Amenorrhoea—Temozolomide—malignant glioma	0.0014	0.0126	CcSEcCtD
Dexamethasone—ANXA1—telencephalon—malignant glioma	0.00136	0.0262	CbGeAlD
Dexamethasone—Leukocytosis—Carmustine—malignant glioma	0.00135	0.0122	CcSEcCtD
Dexamethasone—Herpes simplex—Temozolomide—malignant glioma	0.00133	0.012	CcSEcCtD
Dexamethasone—Skin exfoliation—Carmustine—malignant glioma	0.00122	0.011	CcSEcCtD
Dexamethasone—Neuropathy—Carmustine—malignant glioma	0.0012	0.0108	CcSEcCtD
Dexamethasone—Skin exfoliation—Temozolomide—malignant glioma	0.00117	0.0106	CcSEcCtD
Dexamethasone—Neuropathy—Temozolomide—malignant glioma	0.00115	0.0104	CcSEcCtD
Dexamethasone—Dry eye—Temozolomide—malignant glioma	0.00114	0.0102	CcSEcCtD
Dexamethasone—NR0B1—brain—malignant glioma	0.00113	0.0217	CbGeAlD
Dexamethasone—ANXA1—medulla oblongata—malignant glioma	0.00107	0.0206	CbGeAlD
Dexamethasone—Thrombophlebitis—Carmustine—malignant glioma	0.00107	0.00963	CcSEcCtD
Dexamethasone—Diabetes mellitus—Carmustine—malignant glioma	0.00106	0.00958	CcSEcCtD
Dexamethasone—Thrombophlebitis—Temozolomide—malignant glioma	0.00103	0.0093	CcSEcCtD
Dexamethasone—Eye pain—Carmustine—malignant glioma	0.00102	0.00923	CcSEcCtD
Dexamethasone—PLA2G1B—central nervous system—malignant glioma	0.00101	0.0195	CbGeAlD
Dexamethasone—Injury—Carmustine—malignant glioma	0.00101	0.00907	CcSEcCtD
Dexamethasone—NR3C2—brainstem—malignant glioma	0.000996	0.0191	CbGeAlD
Dexamethasone—Eye pain—Temozolomide—malignant glioma	0.000989	0.00892	CcSEcCtD
Dexamethasone—ANXA1—midbrain—malignant glioma	0.00098	0.0188	CbGeAlD
Dexamethasone—CYP17A1—medulla oblongata—malignant glioma	0.000961	0.0185	CbGeAlD
Dexamethasone—NR3C2—retina—malignant glioma	0.000961	0.0185	CbGeAlD
Dexamethasone—ANXA1—spinal cord—malignant glioma	0.000956	0.0184	CbGeAlD
Dexamethasone—PTGS2—endothelium—malignant glioma	0.000917	0.0176	CbGeAlD
Dexamethasone—CYP11A1—medulla oblongata—malignant glioma	0.000894	0.0172	CbGeAlD
Dexamethasone—NR3C2—telencephalon—malignant glioma	0.000884	0.017	CbGeAlD
Dexamethasone—Affect lability—Temozolomide—malignant glioma	0.000879	0.00793	CcSEcCtD
Dexamethasone—Mood swings—Temozolomide—malignant glioma	0.000846	0.00763	CcSEcCtD
Dexamethasone—PTGS2—blood vessel—malignant glioma	0.000846	0.0163	CbGeAlD
Dexamethasone—Hypokalaemia—Carmustine—malignant glioma	0.000841	0.00758	CcSEcCtD
Dexamethasone—Dry skin—Temozolomide—malignant glioma	0.000818	0.00738	CcSEcCtD
Dexamethasone—Muscular weakness—Carmustine—malignant glioma	0.000815	0.00735	CcSEcCtD
Dexamethasone—Hypokalaemia—Temozolomide—malignant glioma	0.000813	0.00733	CcSEcCtD
Dexamethasone—PLA2G1B—brain—malignant glioma	0.000805	0.0155	CbGeAlD
Dexamethasone—Muscular weakness—Temozolomide—malignant glioma	0.000787	0.0071	CcSEcCtD
Dexamethasone—ANXA1—central nervous system—malignant glioma	0.000776	0.0149	CbGeAlD
Dexamethasone—ANXA1—cerebellum—malignant glioma	0.000758	0.0146	CbGeAlD
Dexamethasone—SLCO1A2—telencephalon—malignant glioma	0.000758	0.0146	CbGeAlD
Dexamethasone—Sweating increased—Temozolomide—malignant glioma	0.000752	0.00678	CcSEcCtD
Dexamethasone—Hyperglycaemia—Carmustine—malignant glioma	0.00072	0.0065	CcSEcCtD
Dexamethasone—Weight increased—Temozolomide—malignant glioma	0.000702	0.00633	CcSEcCtD
Dexamethasone—Weight decreased—Temozolomide—malignant glioma	0.000698	0.0063	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Carmustine—malignant glioma	0.000698	0.00629	CcSEcCtD
Dexamethasone—Hyperglycaemia—Temozolomide—malignant glioma	0.000696	0.00628	CcSEcCtD
Dexamethasone—CYP17A1—central nervous system—malignant glioma	0.000695	0.0134	CbGeAlD
Dexamethasone—NR3C2—medulla oblongata—malignant glioma	0.000694	0.0133	CbGeAlD
Dexamethasone—CYP1B1—telencephalon—malignant glioma	0.000691	0.0133	CbGeAlD
Dexamethasone—Neuropathy peripheral—Temozolomide—malignant glioma	0.000674	0.00608	CcSEcCtD
Dexamethasone—CYP11A1—central nervous system—malignant glioma	0.000647	0.0124	CbGeAlD
Dexamethasone—Haemoglobin—Carmustine—malignant glioma	0.000642	0.00579	CcSEcCtD
Dexamethasone—Haemorrhage—Carmustine—malignant glioma	0.000639	0.00576	CcSEcCtD
Dexamethasone—Hallucination—Carmustine—malignant glioma	0.000636	0.00574	CcSEcCtD
Dexamethasone—NR3C2—midbrain—malignant glioma	0.000635	0.0122	CbGeAlD
Dexamethasone—Haemoglobin—Temozolomide—malignant glioma	0.000621	0.0056	CcSEcCtD
Dexamethasone—NR3C2—spinal cord—malignant glioma	0.000619	0.0119	CbGeAlD
Dexamethasone—Haemorrhage—Temozolomide—malignant glioma	0.000618	0.00557	CcSEcCtD
Dexamethasone—Visual impairment—Carmustine—malignant glioma	0.000616	0.00556	CcSEcCtD
Dexamethasone—ANXA1—brain—malignant glioma	0.000616	0.0118	CbGeAlD
Dexamethasone—Hallucination—Temozolomide—malignant glioma	0.000615	0.00554	CcSEcCtD
Dexamethasone—Eye disorder—Carmustine—malignant glioma	0.000597	0.00539	CcSEcCtD
Dexamethasone—SLCO1A2—medulla oblongata—malignant glioma	0.000595	0.0114	CbGeAlD
Dexamethasone—Visual impairment—Temozolomide—malignant glioma	0.000595	0.00537	CcSEcCtD
Dexamethasone—NR3C1—embryo—malignant glioma	0.000583	0.0112	CbGeAlD
Dexamethasone—Eye disorder—Temozolomide—malignant glioma	0.000577	0.00521	CcSEcCtD
Dexamethasone—Arrhythmia—Carmustine—malignant glioma	0.000571	0.00515	CcSEcCtD
Dexamethasone—Alopecia—Carmustine—malignant glioma	0.000565	0.00509	CcSEcCtD
Dexamethasone—Angiopathy—Temozolomide—malignant glioma	0.00056	0.00505	CcSEcCtD
Dexamethasone—Erythema—Carmustine—malignant glioma	0.000556	0.00502	CcSEcCtD
Dexamethasone—CYP17A1—brain—malignant glioma	0.000552	0.0106	CbGeAlD
Dexamethasone—Alopecia—Temozolomide—malignant glioma	0.000546	0.00492	CcSEcCtD
Dexamethasone—SLCO1A2—midbrain—malignant glioma	0.000544	0.0105	CbGeAlD
Dexamethasone—Erythema—Temozolomide—malignant glioma	0.000538	0.00485	CcSEcCtD
Dexamethasone—NR3C1—brainstem—malignant glioma	0.000534	0.0103	CbGeAlD
Dexamethasone—SLCO1A2—spinal cord—malignant glioma	0.000531	0.0102	CbGeAlD
Dexamethasone—CYP2A6—cerebellum—malignant glioma	0.000524	0.0101	CbGeAlD
Dexamethasone—ABCB1—blood vessel—malignant glioma	0.000523	0.0101	CbGeAlD
Dexamethasone—ABCG2—telencephalon—malignant glioma	0.000515	0.00989	CbGeAlD
Dexamethasone—CYP11A1—brain—malignant glioma	0.000514	0.00987	CbGeAlD
Dexamethasone—PTGS2—embryo—malignant glioma	0.000505	0.0097	CbGeAlD
Dexamethasone—NR3C2—central nervous system—malignant glioma	0.000502	0.00966	CbGeAlD
Dexamethasone—Ill-defined disorder—Temozolomide—malignant glioma	0.000499	0.0045	CcSEcCtD
Dexamethasone—Angioedema—Temozolomide—malignant glioma	0.000491	0.00443	CcSEcCtD
Dexamethasone—NR3C2—cerebellum—malignant glioma	0.000491	0.00944	CbGeAlD
Dexamethasone—Malaise—Temozolomide—malignant glioma	0.000485	0.00437	CcSEcCtD
Dexamethasone—Vertigo—Temozolomide—malignant glioma	0.000483	0.00436	CcSEcCtD
Dexamethasone—Convulsion—Carmustine—malignant glioma	0.000482	0.00435	CcSEcCtD
Dexamethasone—Hypertension—Carmustine—malignant glioma	0.00048	0.00433	CcSEcCtD
Dexamethasone—NR3C1—telencephalon—malignant glioma	0.000474	0.00911	CbGeAlD
Dexamethasone—Myalgia—Carmustine—malignant glioma	0.000474	0.00427	CcSEcCtD
Dexamethasone—Anxiety—Carmustine—malignant glioma	0.000472	0.00426	CcSEcCtD
Dexamethasone—PGR—central nervous system—malignant glioma	0.000467	0.00898	CbGeAlD
Dexamethasone—Convulsion—Temozolomide—malignant glioma	0.000466	0.0042	CcSEcCtD
Dexamethasone—Hypertension—Temozolomide—malignant glioma	0.000464	0.00419	CcSEcCtD
Dexamethasone—Myalgia—Temozolomide—malignant glioma	0.000458	0.00413	CcSEcCtD
Dexamethasone—PGR—cerebellum—malignant glioma	0.000456	0.00877	CbGeAlD
Dexamethasone—Anxiety—Temozolomide—malignant glioma	0.000456	0.00411	CcSEcCtD
Dexamethasone—Oedema—Carmustine—malignant glioma	0.000454	0.0041	CcSEcCtD
Dexamethasone—Discomfort—Temozolomide—malignant glioma	0.000452	0.00408	CcSEcCtD
Dexamethasone—Infection—Carmustine—malignant glioma	0.000451	0.00407	CcSEcCtD
Dexamethasone—CYP2E1—telencephalon—malignant glioma	0.000446	0.00857	CbGeAlD
Dexamethasone—Thrombocytopenia—Carmustine—malignant glioma	0.000445	0.00401	CcSEcCtD
Dexamethasone—Tachycardia—Carmustine—malignant glioma	0.000443	0.004	CcSEcCtD
Dexamethasone—Anaphylactic shock—Temozolomide—malignant glioma	0.000439	0.00396	CcSEcCtD
Dexamethasone—Oedema—Temozolomide—malignant glioma	0.000439	0.00396	CcSEcCtD
Dexamethasone—Infection—Temozolomide—malignant glioma	0.000436	0.00393	CcSEcCtD
Dexamethasone—Anorexia—Carmustine—malignant glioma	0.000433	0.0039	CcSEcCtD
Dexamethasone—SLCO1A2—central nervous system—malignant glioma	0.000431	0.00828	CbGeAlD
Dexamethasone—Nervous system disorder—Temozolomide—malignant glioma	0.00043	0.00388	CcSEcCtD
Dexamethasone—Thrombocytopenia—Temozolomide—malignant glioma	0.00043	0.00387	CcSEcCtD
Dexamethasone—CYP2A6—brain—malignant glioma	0.000426	0.00818	CbGeAlD
Dexamethasone—Hypotension—Carmustine—malignant glioma	0.000424	0.00383	CcSEcCtD
Dexamethasone—Hyperhidrosis—Temozolomide—malignant glioma	0.000424	0.00383	CcSEcCtD
Dexamethasone—SLCO1A2—cerebellum—malignant glioma	0.000421	0.00809	CbGeAlD
Dexamethasone—CYP19A1—central nervous system—malignant glioma	0.00042	0.00808	CbGeAlD
Dexamethasone—Anorexia—Temozolomide—malignant glioma	0.000418	0.00377	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000414	0.00373	CcSEcCtD
Dexamethasone—Insomnia—Carmustine—malignant glioma	0.000411	0.0037	CcSEcCtD
Dexamethasone—PTGS2—telencephalon—malignant glioma	0.00041	0.00789	CbGeAlD
Dexamethasone—Paraesthesia—Carmustine—malignant glioma	0.000408	0.00368	CcSEcCtD
Dexamethasone—ABCG2—medulla oblongata—malignant glioma	0.000404	0.00777	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0004	0.00361	CcSEcCtD
Dexamethasone—NR3C2—brain—malignant glioma	0.000399	0.00767	CbGeAlD
Dexamethasone—CYP2D6—brainstem—malignant glioma	0.000398	0.00764	CbGeAlD
Dexamethasone—Insomnia—Temozolomide—malignant glioma	0.000397	0.00358	CcSEcCtD
Dexamethasone—Decreased appetite—Carmustine—malignant glioma	0.000395	0.00356	CcSEcCtD
Dexamethasone—Paraesthesia—Temozolomide—malignant glioma	0.000394	0.00355	CcSEcCtD
Dexamethasone—CYP1B1—central nervous system—malignant glioma	0.000393	0.00755	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000392	0.00354	CcSEcCtD
Dexamethasone—Pain—Carmustine—malignant glioma	0.000388	0.0035	CcSEcCtD
Dexamethasone—Dyspepsia—Temozolomide—malignant glioma	0.000386	0.00348	CcSEcCtD
Dexamethasone—CYP1B1—cerebellum—malignant glioma	0.000384	0.00738	CbGeAlD
Dexamethasone—Decreased appetite—Temozolomide—malignant glioma	0.000381	0.00344	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000379	0.00342	CcSEcCtD
Dexamethasone—Fatigue—Temozolomide—malignant glioma	0.000378	0.00341	CcSEcCtD
Dexamethasone—Pain—Temozolomide—malignant glioma	0.000375	0.00338	CcSEcCtD
Dexamethasone—Feeling abnormal—Carmustine—malignant glioma	0.000374	0.00337	CcSEcCtD
Dexamethasone—NR3C1—medulla oblongata—malignant glioma	0.000372	0.00716	CbGeAlD
Dexamethasone—Gastrointestinal pain—Carmustine—malignant glioma	0.000371	0.00335	CcSEcCtD
Dexamethasone—PGR—brain—malignant glioma	0.000371	0.00713	CbGeAlD
Dexamethasone—ABCG2—midbrain—malignant glioma	0.00037	0.00711	CbGeAlD
Dexamethasone—Feeling abnormal—Temozolomide—malignant glioma	0.000362	0.00326	CcSEcCtD
Dexamethasone—ABCG2—spinal cord—malignant glioma	0.000361	0.00693	CbGeAlD
Dexamethasone—Body temperature increased—Carmustine—malignant glioma	0.000359	0.00324	CcSEcCtD
Dexamethasone—Abdominal pain—Carmustine—malignant glioma	0.000359	0.00324	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Temozolomide—malignant glioma	0.000359	0.00324	CcSEcCtD
Dexamethasone—CYP2D6—telencephalon—malignant glioma	0.000353	0.00678	CbGeAlD
Dexamethasone—CYP2E1—medulla oblongata—malignant glioma	0.00035	0.00673	CbGeAlD
Dexamethasone—Urticaria—Temozolomide—malignant glioma	0.000349	0.00314	CcSEcCtD
Dexamethasone—Body temperature increased—Temozolomide—malignant glioma	0.000347	0.00313	CcSEcCtD
Dexamethasone—Abdominal pain—Temozolomide—malignant glioma	0.000347	0.00313	CcSEcCtD
Dexamethasone—SLCO1A2—brain—malignant glioma	0.000342	0.00657	CbGeAlD
Dexamethasone—NR3C1—midbrain—malignant glioma	0.00034	0.00654	CbGeAlD
Dexamethasone—CYP19A1—brain—malignant glioma	0.000334	0.00641	CbGeAlD
Dexamethasone—NR3C1—spinal cord—malignant glioma	0.000332	0.00639	CbGeAlD
Dexamethasone—Asthenia—Carmustine—malignant glioma	0.000326	0.00294	CcSEcCtD
Dexamethasone—PTGS2—medulla oblongata—malignant glioma	0.000322	0.0062	CbGeAlD
Dexamethasone—Asthenia—Temozolomide—malignant glioma	0.000315	0.00284	CcSEcCtD
Dexamethasone—CYP2E1—spinal cord—malignant glioma	0.000312	0.006	CbGeAlD
Dexamethasone—ABCB1—embryo—malignant glioma	0.000312	0.006	CbGeAlD
Dexamethasone—CYP1B1—brain—malignant glioma	0.000312	0.006	CbGeAlD
Dexamethasone—Diarrhoea—Carmustine—malignant glioma	0.000311	0.0028	CcSEcCtD
Dexamethasone—Pruritus—Temozolomide—malignant glioma	0.00031	0.0028	CcSEcCtD
Dexamethasone—Dizziness—Carmustine—malignant glioma	0.0003	0.00271	CcSEcCtD
Dexamethasone—Diarrhoea—Temozolomide—malignant glioma	0.0003	0.00271	CcSEcCtD
Dexamethasone—PTGS2—midbrain—malignant glioma	0.000295	0.00566	CbGeAlD
Dexamethasone—Dizziness—Temozolomide—malignant glioma	0.00029	0.00262	CcSEcCtD
Dexamethasone—Vomiting—Carmustine—malignant glioma	0.000289	0.0026	CcSEcCtD
Dexamethasone—PTGS2—spinal cord—malignant glioma	0.000287	0.00553	CbGeAlD
Dexamethasone—Rash—Carmustine—malignant glioma	0.000286	0.00258	CcSEcCtD
Dexamethasone—Dermatitis—Carmustine—malignant glioma	0.000286	0.00258	CcSEcCtD
Dexamethasone—ABCG2—cerebellum—malignant glioma	0.000286	0.0055	CbGeAlD
Dexamethasone—Headache—Carmustine—malignant glioma	0.000284	0.00257	CcSEcCtD
Dexamethasone—Vomiting—Temozolomide—malignant glioma	0.000279	0.00252	CcSEcCtD
Dexamethasone—CYP1A1—central nervous system—malignant glioma	0.000278	0.00534	CbGeAlD
Dexamethasone—Rash—Temozolomide—malignant glioma	0.000277	0.0025	CcSEcCtD
Dexamethasone—Dermatitis—Temozolomide—malignant glioma	0.000276	0.00249	CcSEcCtD
Dexamethasone—ABCB1—retina—malignant glioma	0.000276	0.0053	CbGeAlD
Dexamethasone—Headache—Temozolomide—malignant glioma	0.000275	0.00248	CcSEcCtD
Dexamethasone—CYP2B6—central nervous system—malignant glioma	0.00027	0.00519	CbGeAlD
Dexamethasone—Nausea—Carmustine—malignant glioma	0.00027	0.00243	CcSEcCtD
Dexamethasone—NR3C1—central nervous system—malignant glioma	0.000269	0.00518	CbGeAlD
Dexamethasone—NR3C1—cerebellum—malignant glioma	0.000263	0.00506	CbGeAlD
Dexamethasone—Nausea—Temozolomide—malignant glioma	0.000261	0.00235	CcSEcCtD
Dexamethasone—ABCB1—telencephalon—malignant glioma	0.000254	0.00488	CbGeAlD
Dexamethasone—CYP2E1—central nervous system—malignant glioma	0.000253	0.00487	CbGeAlD
Dexamethasone—CYP2E1—cerebellum—malignant glioma	0.000248	0.00476	CbGeAlD
Dexamethasone—CYP2C8—brain—malignant glioma	0.000239	0.00459	CbGeAlD
Dexamethasone—PTGS2—central nervous system—malignant glioma	0.000233	0.00448	CbGeAlD
Dexamethasone—ABCG2—brain—malignant glioma	0.000232	0.00446	CbGeAlD
Dexamethasone—PTGS2—cerebellum—malignant glioma	0.000228	0.00438	CbGeAlD
Dexamethasone—CYP1A1—brain—malignant glioma	0.00022	0.00424	CbGeAlD
Dexamethasone—CYP2B6—brain—malignant glioma	0.000214	0.00412	CbGeAlD
Dexamethasone—NR3C1—brain—malignant glioma	0.000214	0.00411	CbGeAlD
Dexamethasone—CYP3A4—central nervous system—malignant glioma	0.000204	0.00392	CbGeAlD
Dexamethasone—CYP2E1—brain—malignant glioma	0.000201	0.00387	CbGeAlD
Dexamethasone—CYP2D6—central nervous system—malignant glioma	0.000201	0.00386	CbGeAlD
Dexamethasone—ABCB1—medulla oblongata—malignant glioma	0.000199	0.00383	CbGeAlD
Dexamethasone—CYP2D6—cerebellum—malignant glioma	0.000196	0.00377	CbGeAlD
Dexamethasone—PTGS2—brain—malignant glioma	0.000185	0.00356	CbGeAlD
Dexamethasone—ABCB1—midbrain—malignant glioma	0.000182	0.0035	CbGeAlD
Dexamethasone—ABCB1—spinal cord—malignant glioma	0.000178	0.00342	CbGeAlD
Dexamethasone—CYP2D6—brain—malignant glioma	0.000159	0.00306	CbGeAlD
Dexamethasone—ABCB1—central nervous system—malignant glioma	0.000144	0.00277	CbGeAlD
Dexamethasone—ABCB1—cerebellum—malignant glioma	0.000141	0.00271	CbGeAlD
Dexamethasone—ABCB1—brain—malignant glioma	0.000115	0.0022	CbGeAlD
Dexamethasone—CYP2B6—Metabolism—CAT—malignant glioma	7.05e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HIF1A—malignant glioma	6.97e-06	3.33e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NCOR1—malignant glioma	6.93e-06	3.31e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP3—malignant glioma	6.92e-06	3.3e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL2—malignant glioma	6.91e-06	3.3e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CAT—malignant glioma	6.9e-06	3.3e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CAT—malignant glioma	6.89e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—BCHE—malignant glioma	6.88e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKT1—malignant glioma	6.85e-06	3.27e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS1—malignant glioma	6.81e-06	3.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.8e-06	3.25e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.79e-06	3.24e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.77e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CD—malignant glioma	6.77e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTEN—malignant glioma	6.75e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS1—malignant glioma	6.75e-06	3.22e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CG—malignant glioma	6.74e-06	3.22e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CAV1—malignant glioma	6.74e-06	3.22e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CAV1—malignant glioma	6.73e-06	3.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.72e-06	3.21e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—BCHE—malignant glioma	6.71e-06	3.21e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTP1—malignant glioma	6.69e-06	3.19e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CG—malignant glioma	6.68e-06	3.19e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NCOR1—malignant glioma	6.66e-06	3.18e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC5A5—malignant glioma	6.63e-06	3.17e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MMP9—malignant glioma	6.54e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CB—malignant glioma	6.53e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NCOR1—malignant glioma	6.52e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CD—malignant glioma	6.52e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAT—malignant glioma	6.51e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PPARG—malignant glioma	6.51e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NCOR1—malignant glioma	6.51e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTEN—malignant glioma	6.5e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—malignant glioma	6.47e-06	3.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PPARG—malignant glioma	6.45e-06	3.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.43e-06	3.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.37e-06	3.04e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BAD—malignant glioma	6.34e-06	3.03e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—malignant glioma	6.33e-06	3.02e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—BCHE—malignant glioma	6.33e-06	3.02e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOTCH1—malignant glioma	6.28e-06	3e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—BCHE—malignant glioma	6.27e-06	3e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.25e-06	2.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.22e-06	2.97e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.2e-06	2.96e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—IDH1—malignant glioma	6.19e-06	2.96e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD80—malignant glioma	6.15e-06	2.94e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NCOR1—malignant glioma	6.15e-06	2.94e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APC—malignant glioma	6.14e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTP1—malignant glioma	6.13e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CG—malignant glioma	6.13e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.11e-06	2.92e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGF—malignant glioma	6.07e-06	2.9e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTPN11—malignant glioma	6.03e-06	2.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SPHK1—malignant glioma	5.99e-06	2.86e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAT—malignant glioma	5.97e-06	2.85e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—malignant glioma	5.93e-06	2.83e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CD—malignant glioma	5.93e-06	2.83e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—malignant glioma	5.91e-06	2.82e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CB—malignant glioma	5.9e-06	2.82e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CD—malignant glioma	5.88e-06	2.81e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.87e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—malignant glioma	5.87e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.86e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—malignant glioma	5.84e-06	2.79e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—malignant glioma	5.81e-06	2.78e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.81e-06	2.77e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BRAF—malignant glioma	5.77e-06	2.76e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—malignant glioma	5.76e-06	2.75e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CB—malignant glioma	5.68e-06	2.71e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CAV1—malignant glioma	5.65e-06	2.7e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—malignant glioma	5.64e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NCOR1—malignant glioma	5.64e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—malignant glioma	5.63e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT2—malignant glioma	5.62e-06	2.68e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.55e-06	2.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTP1—malignant glioma	5.47e-06	2.61e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—malignant glioma	5.43e-06	2.59e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CAV1—malignant glioma	5.43e-06	2.59e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—malignant glioma	5.4e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CD—malignant glioma	5.4e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.39e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.39e-06	2.57e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—malignant glioma	5.37e-06	2.57e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—malignant glioma	5.34e-06	2.55e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAT—malignant glioma	5.33e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CAV1—malignant glioma	5.31e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CAV1—malignant glioma	5.3e-06	2.53e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—malignant glioma	5.28e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAT—malignant glioma	5.2e-06	2.48e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGF2—malignant glioma	5.17e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CB—malignant glioma	5.17e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—malignant glioma	5.14e-06	2.46e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CB—malignant glioma	5.12e-06	2.45e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—malignant glioma	5.12e-06	2.44e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—malignant glioma	5.1e-06	2.43e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—malignant glioma	5.07e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.06e-06	2.42e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—malignant glioma	5.03e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NCOR1—malignant glioma	5.03e-06	2.4e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAV1—malignant glioma	5.01e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—malignant glioma	4.99e-06	2.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—malignant glioma	4.99e-06	2.38e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—malignant glioma	4.96e-06	2.37e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—malignant glioma	4.94e-06	2.36e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NCOR1—malignant glioma	4.91e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—malignant glioma	4.91e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAT—malignant glioma	4.9e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAT—malignant glioma	4.86e-06	2.32e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—malignant glioma	4.85e-06	2.32e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—malignant glioma	4.84e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—malignant glioma	4.84e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.83e-06	2.31e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RAF1—malignant glioma	4.82e-06	2.3e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—malignant glioma	4.8e-06	2.29e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.79e-06	2.29e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—malignant glioma	4.77e-06	2.28e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—malignant glioma	4.77e-06	2.28e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—malignant glioma	4.76e-06	2.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—malignant glioma	4.75e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—malignant glioma	4.71e-06	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—malignant glioma	4.69e-06	2.24e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—malignant glioma	4.67e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—malignant glioma	4.66e-06	2.23e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—malignant glioma	4.65e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NCOR1—malignant glioma	4.63e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAV1—malignant glioma	4.59e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NCOR1—malignant glioma	4.59e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—malignant glioma	4.59e-06	2.19e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—malignant glioma	4.56e-06	2.18e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—malignant glioma	4.52e-06	2.16e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—malignant glioma	4.46e-06	2.13e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS1—malignant glioma	4.45e-06	2.13e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—malignant glioma	4.44e-06	2.12e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—malignant glioma	4.43e-06	2.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—malignant glioma	4.43e-06	2.11e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—malignant glioma	4.41e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.39e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—malignant glioma	4.39e-06	2.1e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—malignant glioma	4.35e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—malignant glioma	4.26e-06	2.03e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.25e-06	2.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.18e-06	2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—BCHE—malignant glioma	4.14e-06	1.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAV1—malignant glioma	4.1e-06	1.96e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.09e-06	1.95e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—malignant glioma	4.07e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—malignant glioma	4.06e-06	1.94e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—malignant glioma	4.04e-06	1.93e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—malignant glioma	4.01e-06	1.92e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAV1—malignant glioma	4e-06	1.91e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—malignant glioma	3.98e-06	1.9e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—malignant glioma	3.94e-06	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.92e-06	1.87e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—malignant glioma	3.89e-06	1.86e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—malignant glioma	3.79e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAV1—malignant glioma	3.77e-06	1.8e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—malignant glioma	3.75e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—malignant glioma	3.75e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAV1—malignant glioma	3.74e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.74e-06	1.78e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—malignant glioma	3.71e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.7e-06	1.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.68e-06	1.76e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—malignant glioma	3.68e-06	1.76e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—malignant glioma	3.67e-06	1.75e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—malignant glioma	3.65e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—malignant glioma	3.64e-06	1.74e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—malignant glioma	3.6e-06	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—malignant glioma	3.6e-06	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.57e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—malignant glioma	3.52e-06	1.68e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—malignant glioma	3.5e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—malignant glioma	3.47e-06	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—malignant glioma	3.46e-06	1.65e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.44e-06	1.64e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.41e-06	1.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—malignant glioma	3.41e-06	1.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—malignant glioma	3.38e-06	1.61e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—malignant glioma	3.33e-06	1.59e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—malignant glioma	3.32e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—malignant glioma	3.3e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—malignant glioma	3.29e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—malignant glioma	3.29e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.28e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—malignant glioma	3.27e-06	1.56e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—malignant glioma	3.25e-06	1.55e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.21e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—malignant glioma	3.21e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—malignant glioma	3.2e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAT—malignant glioma	3.2e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—malignant glioma	3.2e-06	1.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—malignant glioma	3.18e-06	1.52e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—malignant glioma	3.15e-06	1.5e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—malignant glioma	3.12e-06	1.49e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.12e-06	1.49e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOR1—malignant glioma	3.02e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—malignant glioma	3.02e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.02e-06	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.99e-06	1.43e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—malignant glioma	2.94e-06	1.4e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—malignant glioma	2.87e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.86e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—malignant glioma	2.86e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—malignant glioma	2.84e-06	1.35e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—malignant glioma	2.83e-06	1.35e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—malignant glioma	2.79e-06	1.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—malignant glioma	2.77e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—malignant glioma	2.77e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.63e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.61e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—malignant glioma	2.61e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—malignant glioma	2.59e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—malignant glioma	2.57e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—malignant glioma	2.55e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—malignant glioma	2.47e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAV1—malignant glioma	2.47e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—malignant glioma	2.41e-06	1.15e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—malignant glioma	2.4e-06	1.15e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—malignant glioma	2.34e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—malignant glioma	2.34e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.31e-06	1.1e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—malignant glioma	2.27e-06	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.26e-06	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.26e-06	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—malignant glioma	2.25e-06	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.25e-06	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—malignant glioma	2.17e-06	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.13e-06	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.97e-06	9.43e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—malignant glioma	1.96e-06	9.37e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.95e-06	9.34e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—malignant glioma	1.89e-06	9.01e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—malignant glioma	1.85e-06	8.82e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—malignant glioma	1.84e-06	8.8e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.74e-06	8.33e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—malignant glioma	1.74e-06	8.32e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.72e-06	8.22e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—malignant glioma	1.71e-06	8.14e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—malignant glioma	1.7e-06	8.13e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.6e-06	7.66e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—malignant glioma	1.6e-06	7.63e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.59e-06	7.6e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—malignant glioma	1.49e-06	7.1e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—malignant glioma	1.43e-06	6.81e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—malignant glioma	1.39e-06	6.64e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—malignant glioma	1.31e-06	6.26e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—malignant glioma	1.3e-06	6.21e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.05e-06	5.01e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—malignant glioma	8.57e-07	4.09e-06	CbGpPWpGaD
